This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
Ira Shafran, MD
Advertisement
Articles by Ira Shafran, MD
Advertisement
Latest Updated Articles
- Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD
Published: April 20th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
3
Gedatolisib Triplet Shows Significant PFS Benefit in HR+/HER2– Breast Cancer
4
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
5
